- Home
- BKU vs XENE Comparison
BKU vs XENE Comparison
Compare BKU & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKU | XENE |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.4B |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BKU | XENE |
|---|---|---|
| Price | $45.13 | $44.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | $42.73 | ★ $53.91 |
| AVG Volume (30 Days) | ★ 1.0M | 821.7K |
| Earning Date | 01-21-2026 | 11-03-2025 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | ★ 44.85 | N/A |
| EPS | ★ 3.54 | N/A |
| Revenue | ★ $1,016,093,000.00 | $7,500,000.00 |
| Revenue This Year | $14.68 | N/A |
| Revenue Next Year | $5.73 | N/A |
| P/E Ratio | $12.80 | ★ N/A |
| Revenue Growth | ★ 10.45 | N/A |
| 52 Week Low | $28.21 | $26.74 |
| 52 Week High | $46.92 | $46.60 |
Technical Indicators
Market Signals| Indicator | BKU | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 64.89 | 58.41 |
| Support Level | $45.33 | $42.44 |
| Resistance Level | $46.33 | $44.57 |
| Average True Range (ATR) | 0.94 | 1.33 |
| MACD | -0.11 | -0.16 |
| Stochastic Oscillator | 44.89 | 40.64 |
Price Performance
Historical ComparisonAbout BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.